BioTuesdays

Tag - Aurinia

Aurinia readies Phase 2b trial in lupus nephritis

Aurinia Pharmaceuticals (TSX-V:AUP) is preparing to begin a Phase 2b clinical trial in the first quarter of 2014 with its voclosporin immunosuppressant in combination with CellCept, the standard of care for treating...

Subscribe

Sign up to our weekly BioTuesdays newsletter.